First Trust Direct Indexing’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-40,755	Closed	-$580K	–	815
2024 Q3	$580K	Sell	40,755 -4,212	-9%	-$59.7K	0.03%	500
2024 Q2	$582K	Sell	44,967 -8,068	-15%	-$107K	0.04%	459
2024 Q1	$737K	Sell	53,035 -12,691	-19%	-$185K	0.05%	367
2023 Q4	$938K	Sell	65,726 -5,332	-8%	-$75.7K	0.08%	276
2023 Q3	$1.1M	Buy	71,058 +12,943	+22%	+$200K	0.13%	178
2023 Q2	$913K	Sell	58,115 -2,729	-4%	-$44.7K	0.1%	236
2023 Q1	$1M	Buy	60,844 +462	+0.8%	+$7.36K	0.12%	209
2022 Q4	$942K	Sell	60,382 -3,097	-5%	-$43.3K	0.12%	217
2022 Q3	$823K	Buy	63,479 +24,560	+63%	+$341K	0.12%	226
2022 Q2	$546K	Buy	38,919 +11,415	+42%	+$163K	0.08%	333
2022 Q1	$394K	Buy	+27,504	New	+$404K	0.05%	423
2021 Q4	–	Sell	-21,842	Closed	-$358K	–	687
2021 Q3	$358K	Buy	21,842 +768	+4%	+$12.9K	0.05%	426
2021 Q2	$355K	Buy	21,074 +10,696	+103%	+$182K	0.05%	422
2021 Q1	$190K	Buy	10,378 +1,306	+14%	+$23.5K	0.05%	379
2020 Q4	$165K	Buy	+9,072	New	+$159K	0.04%	387